home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On Risk Management in Accordance with EN ISO 14971:2012

 
  March 18, 2016  
     
 


Compliance Trainings, Online
2016-04-11


Description :

All industry professionals, regardless of functional roles, will benefit from this training, especially if you are involved in the day-to-day activities associated with your organization’s product development or manufacturing operations. The application of risk management is a salient requirement needed for introducing medical devices that are safe and effective in their intended use.

For organizations that introduce finished medical device into the EU, EN ISO 14971:2012 is considered a Harmonized Standard. Although the use of Harmonized Standards is strongly recommended in the EU, it is nearly an impossible task to gain product application approvals without evidence of compliance with EN ISO 14971:2012. In the United States, the FDA recognizes ISO 14971:2007 as a Consensus Standard.

The application of risk management, although clearly focused on product development, is really applicable throughout the entire product lifecycle. There are many nuances associated with the effective application of 14971; however, there are three salient elements associated with risk management that need to be clearly understood: (a) the Risk Management Plan; (b) the Risk Management File; and (c) the Risk Management Report. When properly employed during product development, risk management tools are vital in support of the design and development of finished medical devices that are safe and effective in their intended use.

Areas Covered in the Session :

General requirements for risk management

The risk management process

Management responsibilities

Qualifications of Personnel

The Risk Management Plan (RMP) and the Risk Management File (RMF)

Elements of risk analysis

The evaluation of risk

Elements of risk control

Evaluation of residual risk

Risk Management Report (RMR)

Production and post-product information

Who Will Benefit:

Quality Departments

Regulatory Departments

Design Engineers

Manufacturing Engineers

 

Project Managers

 
 
Organized by: Compliance Trainings
Invited Speakers:

Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine.

 
Deadline for Abstracts: 2016-04-11
 
Registration:

For more information about this event please visit

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1910

 

To register this webinar

https://compliancetrainings.com/siteengine/Login.aspx 

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.